Patents Assigned to PEPTICOM LTD.
  • Patent number: 11911364
    Abstract: The present invention provides new GABAA receptor-binding compounds that modify the activation of GABAA, their use in the preparation of a neuroactive pharmaceutical composition, improving sperm motility and labeling of biomolecules.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: February 27, 2024
    Assignee: PEPTICOM LTD.
    Inventors: Immanuel Lerner, Amit Michaeli
  • Patent number: 11155578
    Abstract: A group of peptides is provided which activate or inhibit toll-like receptor 4 (TLR4) and may be used to modulate inflammatory signaling and host defense pathways. The peptides were derived in silico and tested in vitro in cell cultures. These peptides may be used in the preparation of immunomodulatory compositions such as vaccine adjuvants and in pharmaceutical compositions for immunomodulation of the innate immune system such as vaccine adjuvants. The peptides may also be used in the preparation of TLR4 activators, TLR4 inhibitors and MD2 labels, e.g., for research purposes.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: October 26, 2021
    Assignee: PEPTICOM LTD.
    Inventors: Amit Michaeli, Immanuel Lerner, Anke Burger-Kentischer, Steffen Rupp